Oncopeptides AB (Oncopeptides AB) FCF Yield % : -48.96 (As of May. 31, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Oncopeptides AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Oncopeptides AB's Trailing 12-Month Free Cash Flow is $-26.29 Mil, and Market Cap is $57.19 Mil. Therefore, Oncopeptides AB's FCF Yield % for today is -48.96%.

The historical rank and industry rank for Oncopeptides AB's FCF Yield % or its related term are showing as below:

ONPPF' s FCF Yield % Range Over the Past 10 Years
Min: -488.15 Med: -45.98 Max: -13.31
Current: -48.96

During the past 10 years, the highest FCF Yield % of Oncopeptides AB was -13.31%. The lowest was -488.15%. And the median was -45.98%.

ONPPF's FCF Yield % is ranked worse than
73.39% of 1552 companies
in the Biotechnology industry
Industry Median: -14.35 vs ONPPF: -48.96

Oncopeptides AB's FCF Margin % for the quarter that ended in Dec. 2023 was -1,038.46%.

Oncopeptides AB FCF Yield % Historical Data

The historical data trend for Oncopeptides AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB FCF Yield % Chart

Oncopeptides AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-12.32

-125.96

-57.61

-54.53

Oncopeptides AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-42.29	-48.02	-40.58	-29.45	-43.21

Competitive Comparison of Oncopeptides AB's FCF Yield %

For the Biotechnology subindustry, Oncopeptides AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncopeptides AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncopeptides AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Oncopeptides AB's FCF Yield % falls into.

Oncopeptides AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Oncopeptides AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-27.258	/	49.986002253
	=	-54.53%

Oncopeptides AB's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-5.4	*	4	/	49.986002253
	=	-43.21%

Oncopeptides AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Oncopeptides AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB (Oncopeptides AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (OTCPK:ONPPF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ONCO:Sweden 0RN4:UK OND:Germany OND:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, SE-111 53

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate melflufen (Ygalo), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and in particular multiple myeloma.